Key result
High-SBP/low-DBP profile linked to ~220% higher cardiovascular risk in STEMI patients after primary PCI.
Why the study?
Elevated SBP increases myocardial oxygen demand while low DBP impairs coronary perfusion, but the prognostic impact of a high-SBP/low-DBP profile in patients with STEMI was unknown.
Does a pre-procedural high-SBP/low-DBP profile predict a higher risk of adverse cardiovascular events in patients with STEMI undergoing primary PCI?
Does a pre-procedural high-SBP/low-DBP profile predict a higher risk of adverse cardiovascular events in patients with STEMI undergoing primary PCI?
A simple pre-procedural blood pressure measurement identifying a high-SBP/low-DBP profile serves as a valuable early risk stratification tool for predicting 1-year adverse cardiovascular events in STEMI patients undergoing primary PCI.
Answers are grounded in this paper and cite their sources.
HSLD profile may aid early risk stratification in STEMI; leaves open whether it should guide therapy or requires prospective validation.
Elevated systolic blood pressure (SBP) increases myocardial oxygen demand, whereas low diastolic blood pressure (DBP) can impair coronary perfusion. The prognostic impact of this high-SBP/low-DBP (HSLD) profile in patients with ST-elevation myocardial infarction (STEMI) remains unknown. We analyzed 696 consecutive patients with STEMI undergoing primary percutaneous coronary intervention (PCI) from a prospective 11-center registry in Japan. Patients were categorized based on pre-procedural SBP (≥ 120 mmHg) and DBP (< 70 mmHg) into four groups: high-SBP/low-DBP (HSLD) high-SBP/high-DBP (HSHD), low-SBP/high-DBP (LSHD), and low-SBP/low-DBP (LSLD). The primary endpoint was a 1-year composite of cardiovascular death, non-fatal myocardial infarction, or stroke. Median follow-up was 369 days. The 1-year cumulative incidence of the primary endpoint was 7 (9.5%) in the HSLD group, 19 (4.2%) in the HSHD group, 2 (2.8%) in the LSHD group, and 5 (6.0%) in the LSLD group (log-rank p = 0.007). In multivariable Cox regression, the HSLD was independently associated with the primary endpoint compared to the HSHD group (hazard ratio 3.20, 95% CI 1.04-9.87; p = 0.043). The prognostic value of HSLD was consistent across major subgroups. A pre-procedural blood pressure pattern of SBP ≥ 120 mmHg combined with DBP < 70 mmHg independently predicts a higher risk of adverse cardiovascular events at 1 year in patients with STEMI. This simple measurement at admission identifies a previously unrecognized high-risk phenotype and presents a valuable opportunity for early risk stratification.
No takes yet. Share an insight, caveat, or question.
Muangsillapasart et al. (2025) studied this question. A high-systolic/low-diastolic blood pressure profile was associated with a 3.20 higher risk of adverse cardiovascular events in STEMI patients after primary PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: